Edition:
United Kingdom

Epizyme Inc (EPZM.OQ)

EPZM.OQ on NASDAQ Stock Exchange Global Select Market

17.20USD
7:42pm GMT
Change (% chg)

$-0.15 (-0.86%)
Prev Close
$17.35
Open
$17.50
Day's High
$17.65
Day's Low
$17.15
Volume
19,940
Avg. Vol
127,033
52-wk High
$20.40
52-wk Low
$9.35

Chart for

About

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The Company is engaged in the discovery and development of novel epigenetic therapies for cancer patients. The Company develops small molecule inhibitors of a class of... (more)

Overall

Beta: 2.21
Market Cap(Mil.): $1,257.42
Shares Outstanding(Mil.): 67.79
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Epizyme announces pricing of public offering of common stock

* Epizyme announces pricing of public offering of common stock

14 Sep 2017

Competitors

  Price Chg
Eisai Co., Ltd (4523.T) ¥5,570 -40.00
Novartis AG (NOVN.S) CHF79.98 -0.22
GlaxoSmithKline plc (GSK.L) 1,303.00 -21.60
Celgene Corporation (CELG.OQ) $94.31 +0.42

Earnings vs. Estimates